CSIMarket
 


Natus Medical Inc  (NTUS)
Other Ticker:  
 
 

NTUS's Capital Expenditures Growth by Quarter and Year

Natus Medical Inc's Capital Expenditures results by quarter and year




NTUS Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.67 0.69 0.95
III Quarter September - 0.98 3.35 0.00
II Quarter June - 1.24 3.58 2.08
I Quarter March 1.06 0.73 1.45 1.21
FY   1.06 3.62 9.07 4.24



NTUS Capital Expenditures first quarter 2022 Y/Y Growth Comment
Natus Medical Inc achieved in the first quarter 2022, above Company average Capital Expenditures rise of 45.48% year on year, to $ 1.06 millions.

Looking into first quarter 2022 results within Medical Equipment & Supplies industry 52 other companies have achieved higher Capital Expenditures growth. While Natus Medical Inc' s Capital Expenditures jump of 45.48% ranks overall at the positon no. 1035 in the first quarter 2022.




NTUS Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -2.9 % -27.37 % -61.54 %
III Quarter September - -70.75 % - -
II Quarter June - -65.36 % 72.12 % 61.24 %
I Quarter March 45.48 % -49.66 % 19.83 % 146.94 %
FY   - -60.09 % 113.92 % -23.88 %

Financial Statements
Natus Medical Inc's first quarter 2022 Capital Expenditures $ 1.06 millions NTUS's Income Statement
Natus Medical Inc's first quarter 2021 Capital Expenditures $ 0.73 millions Quarterly NTUS's Income Statement
New: More NTUS's historic Capital Expenditures Growth >>


NTUS Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -31.63 % -79.4 % -
III Quarter September - -20.97 % -6.42 % -
II Quarter June - 69.86 % 146.9 % 71.9 %
I Quarter March 58.51 % 5.8 % 52.63 % -51.01 %
FY (Year on Year)   - -60.09 % 113.92 % -23.88 %




Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #53
Healthcare Sector #194
Overall #1035

Capital Expenditures Y/Y Growth Statistics
High Average Low
196.32 % 8.87 % -58.59 %
(Jun 30 2020)   (Jun 30 2019)
Capital Expenditures first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #53
Healthcare Sector #194
Overall #1035
Capital Expenditures Y/Y Growth Statistics
High Average Low
196.32 % 8.87 % -58.59 %
(Jun 30 2020)   (Jun 30 2019)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Natus Medical Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
2304.76 % 91.35 % -100 %
(Dec 31 2016)  


NTUS's I. Quarter Q/Q Capital Expenditures Comment
Natus Medical Inc achieved in the I. Quarter 2022 below company average Capital Expenditures jump of 58.51% quarter on quarter, to $ 1.06 millions.

Although the I. Quarter 2022 NTUS's Capital Expenditures quarter on quarter growth was lower than the average of 91.35 %, that has been yet good news, as the current expension, outshines the 5.8% growth in the I. Quarter a year ago

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Natus Medical Inc's Capital Expenditures growth quarter on quarter, overall rank is 637.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #170
Overall #637
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #170
Overall #637
Capital Expenditures Q/Q Growth Statistics
High Average Low
2304.76 % 91.35 % -100 %
(Dec 31 2016)  


NTUS's I. Quarter Q/Q Capital Expenditures Comment
Natus Medical Inc achieved in the I. Quarter 2022 below company average Capital Expenditures jump of 58.51% quarter on quarter, to $ 1.06 millions.

I. Quarter 2022 performance appear to be paradoxical, although lower than the average increase of 91.35 %, yet it shows absolute acceleration compare to the 5.8% in the I. Quarter 2021

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Natus Medical Inc's Capital Expenditures growth quarter on quarter, overall rank is 637.


Natus Medical Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 3.95 $ 3.62 $ 3.64 $ 6.01 $ 8.35
Y / Y Capital Expenditures Growth (TTM) -52.67 % -60.09 % -61.01 % 90.76 % 404.72 %
Year on Year Capital Expenditures Growth Overall Ranking # 2345 # 2048 # 2026 # 359 # 104
Seqeuential Capital Expenditures Change (TTM) 9.14 % -0.52 % -39.44 % -28.02 % -7.97 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1035 # 1482 # 2277 # 2599 # 1945




Cumulative Capital Expenditures growth Comment
Natus Medical Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Dec 31 2021. If the fiscal year would end in Mar 31 2022, Natus Medical Inc's annual Capital Expenditures decrease would be -52.67% year on year to $4 millions.

In the Healthcare sector 386 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 2048 to 2345.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
196.32 %
8.87 %
-58.59 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 53
Healthcare Sector # 387
Overall # 2345

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
542.42 %
40.08 %
-74.64 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 53
Sector # 194
S&P 500 # 1035
Cumulative Capital Expenditures growth Comment
Natus Medical Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Dec 31 2021. If the fiscal year would end in Mar 31 2022, Natus Medical Inc's annual Capital Expenditures drop would be -52.67% year on year to $4 millions.

In the Healthcare sector 386 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 2048 to 2345.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
196.32 %
8.87 %
-58.59 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 53
Healthcare Sector # 387
Overall # 2345

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
542.42 %
40.08 %
-74.64 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 53
Sector # 194
S&P 500 # 1035




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
NTUS's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for NTUS's Competitors
Capital Expenditures Growth for Natus Medical Inc's Suppliers
Capital Expenditures Growth for NTUS's Customers

You may also want to know
NTUS's Annual Growth Rates NTUS's Profitability Ratios NTUS's Asset Turnover Ratio NTUS's Dividend Growth
NTUS's Roe NTUS's Valuation Ratios NTUS's Financial Strength Ratios NTUS's Dividend Payout Ratio
NTUS's Roa NTUS's Inventory Turnover Ratio NTUS's Growth Rates NTUS's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2022
Resmed Inc 78.96%$ 78.963 millions
Ngm Biopharmaceuticals Inc 78.13%$ 78.125 millions
Quotient Limited77.90%$ 77.900 millions
Agile Therapeutics Inc77.46%$ 77.465 millions
Alimera Sciences Inc 77.38%$ 77.381 millions
Surmodics Inc76.61%$ 76.606 millions
Reneo Pharmaceuticals Inc 76.00%$ 76.000 millions
Actinium Pharmaceuticals Inc 75.00%$ 75.000 millions
Ocular Therapeutix Inc 74.68%$ 74.684 millions
Tivity Health Inc 73.93%$ 73.927 millions
Axogen inc 72.78%$ 72.778 millions
Clearpoint Neuro Inc 72.50%$ 72.500 millions
Vor Biopharma Inc 71.73%$ 71.734 millions
Option Care Health Inc 71.60%$ 71.598 millions
Nkarta Inc 71.35%$ 71.346 millions
Passage Bio inc 71.02%$ 71.022 millions
Orgenesis Inc 70.19%$ 70.189 millions
Sotera Health Company69.74%$ 69.735 millions
Neurocrine Biosciences Inc 68.89%$ 68.889 millions
Aligos Therapeutics Inc 67.75%$ 67.752 millions
Organon and Co 65.79%$ 65.789 millions
Healthcare Services Group Inc 65.53%$ 65.529 millions
Owens and Minor inc65.50%$ 65.499 millions
Icu Medical Inc63.46%$ 63.457 millions
Athersys Inc63.16%$ 63.158 millions
Intuitive Surgical Inc 62.29%$ 62.287 millions
Avantor Inc 62.25%$ 62.252 millions
Hims and Hers Health Inc 61.52%$ 61.519 millions
Boston Scientific Corporation61.33%$ 61.333 millions
Ufp Technologies Inc 61.08%$ 61.077 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com